decisionhealth Newsletters, Part B News - 2002 Issue 12 (December)
Jan. 1 start date set for national drug reimbursement prices
Subscribe or sign in to view the full article.
Article Overview
This article covers a CMS announcement about standardizing national pricing for certain physician-administered Medicare Part B drugs, the planned implementation date, and the role of a selected carrier in generating the pricing files. It also discusses why the change matters to physicians, how it relates to carrier-level payment variation, and the larger congressional debate over drug reimbursement methodology. The piece is relevant to medical billing professionals, physician practices, Medicare stakeholders, and policy readers following Part B drug payment changes.
Why This Topic Matters
Medicare Part B drug reimbursement affects physician office payments and can vary by carrier, so a national pricing approach can change reimbursement outcomes and administrative processes across the country. The article also places the CMS action within ongoing federal efforts to address broader payment reform and Medicare spending.
What You Will Learn
- How CMS planned to standardize pricing for Medicare Part B office-administered drugs
- Why carrier-to-carrier payment variation mattered to physicians and Medicare
- Which organizations and policy discussions were involved in the reimbursement change
- How the announcement fit into wider debates over drug reimbursement reform
Who Should Read This
- Medical coders
- Billing and reimbursement professionals
- Physician practice managers
- Medicare policy analysts
- Healthcare administrators
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com